1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Predictors of response to treatment with peginterferon plus ribavirin are well established. In these post-hoc analyses of the REALIZE study, we sought to identify predictors of response for telaprevir-based triple therapy.

          Related collections

          Author and article information

          Journal
          Liver Int.
          Liver international : official journal of the International Association for the Study of the Liver
          Wiley
          1478-3231
          1478-3223
          Feb 2015
          : 35
          : 2
          Affiliations
          [1 ] Universitätsklinikum Leipzig, Sektion Hepatologie, Klinik für Gastroenterologie und Rheumatologie, Leipzig, Germany.
          Article
          10.1111/liv.12703
          25319731
          eacd31bb-931f-489e-aeea-2f8baa92cbd6
          History

          HCV,LDL,predictors,response,REALIZE,telaprevir
          HCV, LDL, predictors, response, REALIZE, telaprevir

          Comments

          Comment on this article